Literature DB >> 32833198

A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer.

Davide Cusumano1, Gert Meijer2, Jacopo Lenkowicz3, Giuditta Chiloiro1, Luca Boldrini1, Carlotta Masciocchi4, Nicola Dinapoli1, Roberto Gatta4, Calogero Casà4, Andrea Damiani4, Brunella Barbaro1, Maria Antonietta Gambacorta1, Luigi Azario1, Marco De Spirito1, Martijn Intven2, Vincenzo Valentini1.   

Abstract

PURPOSE: Aim of this study was to develop a generalised radiomics model for predicting pathological complete response after neoadjuvant chemo-radiotherapy in locally advanced rectal cancer patients using pre-CRT T2-weighted images acquired at a 1.5 T and a 3 T scanner.
METHODS: In two institutions, 195 patients were scanned: 136 patients were scanned on a 1.5 T MR scanner, 59 patients on a 3 T MR scanner. Gross tumour volumes were delineated on the MR images and 496 radiomic features were extracted, applying the intensity-based (IB) filter. Features were standardised with Z-score normalisation and an initial feature selection was carried out using Wilcoxon-Mann-Whitney test: The most significant features at 1.5 T and 3 T were selected as main features. Several logistic regression models combining the main features with a third one selected by those resulting significant were elaborated and evaluated in terms of area under curve (AUC). A tenfold cross-validation was repeated 300 times to evaluate the model robustness.
RESULTS: Three features were selected: maximum fractal dimension with IB = 0-50, energy and grey-level non-uniformity calculated on the run-length matrix with IB = 0-50. The AUC of the model applied to the whole dataset after cross-validation was 0.72, while values of 0.70 and 0.83 were obtained when 1.5 T and 3 T patients were considered, respectively.
CONCLUSIONS: The model elaborated showed good performance, even when data from patients scanned on 1.5 T and 3 T were merged. This shows that magnetic field intensity variability can be overcome by means of selecting appropriate image features.

Entities:  

Keywords:  Inter-scanner variability; Magnetic field intensity; Magnetic resonance imaging; Radiomics; Rectal cancer

Year:  2020        PMID: 32833198     DOI: 10.1007/s11547-020-01266-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  27 in total

1.  Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.

Authors:  Vincenzo Valentini; Ruud G P M van Stiphout; Guido Lammering; Maria Antonietta Gambacorta; Maria Cristina Barba; Marek Bebenek; Franck Bonnetain; Jean-Francois Bosset; Krzysztof Bujko; Luca Cionini; Jean-Pierre Gerard; Claus Rödel; Aldo Sainato; Rolf Sauer; Bruce D Minsky; Laurence Collette; Philippe Lambin
Journal:  J Clin Oncol       Date:  2011-07-11       Impact factor: 44.544

Review 2.  Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  S T Martin; H M Heneghan; D C Winter
Journal:  Br J Surg       Date:  2012-02-23       Impact factor: 6.939

Review 3.  Rectal and colon cancer: Not just a different anatomic site.

Authors:  K Tamas; A M E Walenkamp; E G E de Vries; M A T M van Vugt; R G Beets-Tan; B van Etten; D J A de Groot; G A P Hospers
Journal:  Cancer Treat Rev       Date:  2015-06-28       Impact factor: 12.111

4.  Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer.

Authors:  Vincenzo Valentini; Ruud G P M van Stiphout; Guido Lammering; Maria A Gambacorta; Maria C Barba; Marek Bebenek; Franck Bonnetain; Jean F Bosset; Krzysztof Bujko; Luca Cionini; Jean P Gerard; Claus Rödel; Aldo Sainato; Rolf Sauer; Bruce D Minsky; Laurence Collette; Philippe Lambin
Journal:  Radiother Oncol       Date:  2015-02-21       Impact factor: 6.280

5.  Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Authors:  Monique Maas; Patty J Nelemans; Vincenzo Valentini; Prajnan Das; Claus Rödel; Li-Jen Kuo; Felipe A Calvo; Julio García-Aguilar; Rob Glynne-Jones; Karin Haustermans; Mohammed Mohiuddin; Salvatore Pucciarelli; William Small; Javier Suárez; George Theodoropoulos; Sebastiano Biondo; Regina G H Beets-Tan; Geerard L Beets
Journal:  Lancet Oncol       Date:  2010-08-06       Impact factor: 41.316

Review 6.  Locally advanced rectal cancer: the importance of a multidisciplinary approach.

Authors:  Rossana Berardi; Elena Maccaroni; Azzurra Onofri; Francesca Morgese; Mariangela Torniai; Michela Tiberi; Consuelo Ferrini; Stefano Cascinu
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

7.  Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.

Authors:  Andrew G Renehan; Lee Malcomson; Richard Emsley; Simon Gollins; Andrew Maw; Arthur Sun Myint; Paul S Rooney; Shabbir Susnerwala; Anthony Blower; Mark P Saunders; Malcolm S Wilson; Nigel Scott; Sarah T O'Dwyer
Journal:  Lancet Oncol       Date:  2015-12-17       Impact factor: 41.316

8.  Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.

Authors:  Cécile Ortholan; Pascale Romestaing; Olivier Chapet; Jean Pierre Gerard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-01       Impact factor: 7.038

9.  Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.

Authors:  Mit Dattani; Richard J Heald; Ghaleb Goussous; Jack Broadhurst; Guilherme P São Julião; Angelita Habr-Gama; Rodrigo Oliva Perez; Brendan J Moran
Journal:  Ann Surg       Date:  2018-12       Impact factor: 12.969

10.  Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies.

Authors:  Claudio Belluco; Antonino De Paoli; Vincenzo Canzonieri; Roberto Sigon; Mara Fornasarig; Angela Buonadonna; Giovanni Boz; Roberto Innocente; Tiziana Perin; Marta Cossaro; Jerry Polesel; Francesco De Marchi
Journal:  Ann Surg Oncol       Date:  2011-06-21       Impact factor: 5.344

View more
  35 in total

1.  Radiomics textural features by MR imaging to assess clinical outcomes following liver resection in colorectal liver metastases.

Authors:  Vincenza Granata; Roberta Fusco; Federica De Muzio; Carmen Cutolo; Sergio Venanzio Setola; Roberta Grassi; Francesca Grassi; Alessandro Ottaiano; Guglielmo Nasti; Fabiana Tatangelo; Vincenzo Pilone; Vittorio Miele; Maria Chiara Brunese; Francesco Izzo; Antonella Petrillo
Journal:  Radiol Med       Date:  2022-03-26       Impact factor: 3.469

2.  Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.

Authors:  Giuditta Chiti; Giulia Grazzini; Federica Flammia; Benedetta Matteuzzi; Paolo Tortoli; Silvia Bettarini; Elisa Pasqualini; Vincenza Granata; Simone Busoni; Luca Messserini; Silvia Pradella; Daniela Massi; Vittorio Miele
Journal:  Radiol Med       Date:  2022-08-02       Impact factor: 6.313

Review 3.  A narrative review on current imaging applications of artificial intelligence and radiomics in oncology: focus on the three most common cancers.

Authors:  Simone Vicini; Chandra Bortolotto; Marco Rengo; Daniela Ballerini; Davide Bellini; Iacopo Carbone; Lorenzo Preda; Andrea Laghi; Francesca Coppola; Lorenzo Faggioni
Journal:  Radiol Med       Date:  2022-06-30       Impact factor: 6.313

4.  Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models.

Authors:  Iram Shahzadi; Alex Zwanenburg; Annika Lattermann; Annett Linge; Christian Baldus; Jan C Peeken; Stephanie E Combs; Markus Diefenhardt; Claus Rödel; Simon Kirste; Anca-Ligia Grosu; Michael Baumann; Mechthild Krause; Esther G C Troost; Steffen Löck
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

5.  Radiomics and machine learning analysis based on magnetic resonance imaging in the assessment of liver mucinous colorectal metastases.

Authors:  Vincenza Granata; Roberta Fusco; Federica De Muzio; Carmen Cutolo; Sergio Venanzio Setola; Federica Dell'Aversana; Francesca Grassi; Andrea Belli; Lucrezia Silvestro; Alessandro Ottaiano; Guglielmo Nasti; Antonio Avallone; Federica Flammia; Vittorio Miele; Fabiana Tatangelo; Francesco Izzo; Antonella Petrillo
Journal:  Radiol Med       Date:  2022-06-02       Impact factor: 6.313

6.  Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Giovanna Vacca; Giuliana Giacobbe; Antonio Angrisani; Alfredo Clemente; Ginevra Danti; Pierpaolo Correale; Salvatore Francesco Carbone; Luigi Pirtoli; Lorenzo Bianchi; Angelo Vanzulli; Cesare Guida; Roberto Grassi; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

7.  Structured Reporting of Rectal Cancer Staging and Restaging: A Consensus Proposal.

Authors:  Vincenza Granata; Damiano Caruso; Roberto Grassi; Salvatore Cappabianca; Alfonso Reginelli; Roberto Rizzati; Gabriele Masselli; Rita Golfieri; Marco Rengo; Daniele Regge; Giuseppe Lo Re; Silvia Pradella; Roberta Fusco; Lorenzo Faggioni; Andrea Laghi; Vittorio Miele; Emanuele Neri; Francesca Coppola
Journal:  Cancers (Basel)       Date:  2021-04-28       Impact factor: 6.639

8.  Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.

Authors:  Giuditta Chiloiro; Davide Cusumano; Paola de Franco; Jacopo Lenkowicz; Luca Boldrini; Davide Carano; Brunella Barbaro; Barbara Corvari; Nicola Dinapoli; Martina Giraffa; Elisa Meldolesi; Riccardo Manfredi; Vincenzo Valentini; Maria Antonietta Gambacorta
Journal:  Radiol Med       Date:  2021-11-01       Impact factor: 3.469

Review 9.  Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma.

Authors:  Vincenza Granata; Roberta Grassi; Roberta Fusco; Andrea Belli; Carmen Cutolo; Silvia Pradella; Giulia Grazzini; Michelearcangelo La Porta; Maria Chiara Brunese; Federica De Muzio; Alessandro Ottaiano; Antonio Avallone; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2021-07-19       Impact factor: 2.965

Review 10.  Large Bowel Ischemia/Infarction: How to Recognize It and Make Differential Diagnosis? A Review.

Authors:  Francesca Iacobellis; Donatella Narese; Daniela Berritto; Antonio Brillantino; Marco Di Serafino; Susanna Guerrini; Roberta Grassi; Mariano Scaglione; Maria Antonietta Mazzei; Luigia Romano
Journal:  Diagnostics (Basel)       Date:  2021-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.